Notch dependent chromatin remodeling enables Gata3 binding and drives lineage specific CD8 + T cell function
Immunology & Cell Biology · 2025
DOI: 10.1111/imcb.70002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, 2025. Verfasst von Jessie O'Hara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Monash Biomedical Institute, Monash University, Clayton, VIC, Australia. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, CD8-Positive T-Lymphocytes, Receptors, Notch, Chromatin Assembly and Disassembly. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council.
Abstract (Originalsprache)
Activation of CD8 + T cells enable them to control virus infections and tumors. This process involves the differentiation of naïve CD8 + T cells into effector and memory states, driven by specific transcription factors (TFs). Previously, we have shown that Granzyme A (Gzma) induction in activated CD8 + T cells depends on Gata3 and the establishment of a permissive chromatin landscape at the Gzma locus. Interestingly, Gzma expression is independent of IL‐4 signaling, which typically upregulates Gata3 in CD4 + T cells, suggesting an alternative pathway for Gata3 induction. Here we demonstrate that Notch signals during CD8 + T cell activation promote Gzma expression. Inhibition of Notch signaling or loss of the Notch transactivator Rbp‐j leads to reduced Gzma expression, with transcriptionally repressive chromatin at the Gzma locus. The genome targets of Gata3 differ in effector CD8 + T cells activated with IL‐4 compared with those activated with Notch signals or isolated after IAV infection. This indicates that the signals received during CD8 + T cell activation can alter the chromatin landscape, affecting Gata3 function. Furthermore, Gata3 deficiency results in reduced IAV‐specific CD8 + T cell responses and decreased Gzma expression, although the Gzma locus maintains a permissive chromatin landscape. These findings suggest that Notch signals received by virus‐specific CD8 + T cells prepare the chromatin landscape for Gata3 binding to CD8 + lineage‐specific gene loci, promoting effective CD8 + T cell immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Monash Biomedical Institute, Monash University, Clayton, VIC, Australia.
- Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, Australia.
- Monash Bioinformatics Platform, Monash Biomedical Discovery Institute, Monash University, Clayton, VIC, Australia.
ORCID-Profile: Taylah J Bennett, Nicholas Murray, Stephen J Turner
Förderung
- Australian Research Council
- National Health and Medical Research Council
Zitieren
APA
O'Hara, J., Dakle, P., Nguyen, M. L. T., Barugahare, A., Bennett, T. J., Udupa, V. A., Murray, N., Schlegel, G., Kapouleas, C., Li, J., Turner, S. J., & Russ, B. E. (2025). Notch dependent chromatin remodeling enables Gata3 binding and drives lineage specific CD8 + T cell function. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70002
Vancouver
O'Hara J, Dakle P, Nguyen MLT, Barugahare A, Bennett TJ, Udupa VA, et al. Notch dependent chromatin remodeling enables Gata3 binding and drives lineage specific CD8 + T cell function. Immunology & Cell Biology. 2025. doi:10.1111/imcb.70002
BibTeX
@article{OHara2025,
author = {O'Hara, Jessie and Dakle, Pushkar and Nguyen, Michelle Ly Thai and Barugahare, Adele and Bennett, Taylah J and Udupa, Vibha Av and Murray, Nicholas and Schlegel, Gemma and Kapouleas, Constantine and Li, Jasmine and Turner, Stephen J and Russ, Brendan E},
title = {Notch dependent chromatin remodeling enables Gata3 binding and drives lineage specific CD8 + T cell function},
journal = {Immunology & Cell Biology},
year = {2025},
doi = {10.1111/imcb.70002}
}
EUVIMED